Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03524326
Title Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

oropharynx cancer

skin squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Cetuximab + Lenvatinib

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.